Richman Michael 4
4 · NextCure, Inc. · Filed Mar 1, 2023
Insider Transaction Report
Form 4
NextCure, Inc.NXTC
Richman Michael
DirectorPresident & CEO
Transactions
- Award
Employee Stock Option (Right to Buy)
2023-02-28+309,000→ 309,000 totalExercise: $1.55Exp: 2033-02-27→ Common Stock (309,000 underlying)
Footnotes (1)
- [F1]One fourth of the option vests on February 28, 2024. The remainder vests in 36 monthly installments beginning on March 28, 2024.